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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: The prominent side effect of the immunosuppressive drug cyclosporine
A (CsA) is gingival overgrowth. Hypoxia-inducible factor (HIF)-1a regulates a wide variety of
profibrogenic genes, which are closely associated with tissue fibrosis. The aim of this study
was to compare HIF-1a expression in normal gingival tissues and CsA-induced gingival over-
growth specimens and further explore the potential mechanisms that may lead to induction
of HIF-1a expression.
Methods: Fifteen CsA-induced gingival overgrowth specimens and five normal gingival tissues
were examined by immunohistochemistry. Western blot was used to investigate the effects
of CsA on the expression of HIF-1a in cultured human gingival fibroblasts. The effects of CsA
on plasminogen activator inhibitor (PAI)-1 expression were evaluated in environmental
hypoxia.
Results: HIF-1a staining in gingival tissue was stronger in CsA-induced gingival overgrowth
group than normal gingival group (p < 0.05). The expression of HIF-1a was significantly higher
in CsA-induced gingival overgrowth specimens with higher levels of inflammatory infiltrates
(p Z 0.041). CsA was found to upregulate HIF-1a protein in a dose-dependent mannerentistry, Chung Shan Medical University, 110, Section 1, Chien-Kuo North Road, Taichung, Taiwan.
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Hypoxia and gingival overgrowth 59(p < 0.05). Hypoxia increased CsA-induced PAI-1 protein expression than normoxic conditions
(p < 0.05).
Conclusion: These results suggest that HIF-1a expression is significantly upregulated in CsA-
induced gingival overgrowth specimens. The activation of HIF-1a may promote fibrogenesis
by an increase of PAI-1 expression and a subsequent elevation of extracellular matrix produc-
tion in gingival tissues.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Cyclosporine A (CsA) is a cyclic polypeptide used as an
immunosuppressive drug. It is widely used to prevent organ
transplant rejection and to treat various immunological
diseases. Gingival overgrowth is a prominent side effect
associated with the systemic use of CsA.1 Gingival over-
growth as a clinical outcome presents as an increased
gingival volume, including an increased number of cells and
a higher level of extracellular matrix (ECM) production.2
Despite extensive research, the precise mechanism under-
lying the pathogenesis of CsA-induced gingival outgrowth is
still unclear.
A key mediator of cellular responses to low oxygen is
hypoxia inducible factor-1 (HIF-1), a heterodimeric tran-
scription factor consisting of a constitutively expressed
b subunit (also known as aryl hydrocarbon receptor
nuclear translocator) and an O2-regulated a subunit. In
normoxia, the HIF-1a subunit is a short-lived polypeptide
that undergoes rapid oxygen-dependent hydroxylation on
specific proline and asparagine residues by prolyl
hydroxylases. In the presence of oxygen, prolyl hydroxy-
lase domain enzymes hydroxylate HIF-1a and enable
interaction with von Hippel-Lindau protein, which results
in its ubiquitylation and subsequent proteasomal degra-
dation.3 HIF-1 also induces expression of profibrogenic
genes such as tissue inhibitor of metalloproteinase-1,
connective tissue growth factor, and plasminogen acti-
vator inhibitor (PAI)-1.4e6 It is thus likely that by upre-
gulating these profibrogenic factors, HIF-1 accelerates
tissue fibrosis. In addition, HIF-1a is consistently and
dramatically upregulated in a variety of fibrotic diseases,
such as keloid,7 renal fibrosis,8 and oral submucous
fibrosis.9
Recently, HIF-1a was found to be expressed in healthy
and diseased periodontal tissues.10 However, little is known
about the correlation between HIF-1a and CsA-induced
gingival overgrowth. The present work was undertaken to
identify the in situ localization of HIF-1a expression in
normal gingival tissues and CsA-induced gingival overgrowth
specimens. In addition, western blot was used to determine
the effects of CsA on the expression of HIF-1a in cultured
human gingival fibroblasts (HGFs) in vitro. Previous findings
have suggested that hypoxia, through HIF-1, could enhance
fibrogenesis via factors involved in ECM modification, such
as PAI-1.11 Recently, our study has shown that PAI-1
expression is significantly upregulated in CsA-induced
gingival overgrowth specimens.12 To address the mecha-
nisms underlying the hypoxic regulation of PAI-1 expression,
the effects of CsA on HGFs were studied in a hypoxia
chamber.Materials and methods
Tissue collection
Normal gingival tissue samples were obtained from five
healthy individuals undergoing routine surgical crown
lengthening, with little if any evidence of inflammation and
no systemic medication. Fifteen redundant hyperplasic
gingival biopsy materials were obtained from 10 renal trans-
plant patients (4 women and 6 men) receiving CsA therapy.
The average age of the patients was 52  12 years. These
patients had been taking CsA for more than 1 year and the
dose had been adjusted to maintain stable serum levels of
about 200 ng/ml. No sign of graft rejection was detected in
these renal transplant patients. The samples were obtained
during surgical removal of diseased gingiva as part of their
routine clinical management, which also included intensive
plaque control. Institutional Review Board permission at the
Chung Shan Medical University Hospital was obtained for the
use of discarded human tissue.Immunohistochemistry
The surgically removed gingival tissues were fixed with 10%
buffered formalin overnight, the specimens were dehy-
drated in an ascending series of graded alcohols and
embedded in paraffin. Sections (5 mm thick)_were stained
with the monoclonal anti-HIF-1a (sc-10790) antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) (1:100 dilution)
using a standard avidin-biotin-peroxidase complex
method,13,14 and 3-amino-9-ethylcarbazole (AEC; DAKO,
Carpinteria, CA, USA) was then used as the substrate for
localizing the antibody binding. Negative controls included
serial sections from which either the primary or secondary
antibodies were excluded. The preparations were coun-
terstained with hematoxylin, mounted with Permount
(Merck, Darmstadt, Germany) and examined by light
microscopy.
One section from each CsA-induced gingival overgrowth
specimen was stained with hematoxylin and eosin to eval-
uate the magnitude of inflammation at the histological
level. Most of the inflammatory cells present in the infil-
trates represented in these specimens were lymphocytes.
Each specimen was graded at 200x magnification as: grade
low, inflammatory cells <50% per field and grade high,
inflammatory cells >50% per field. Grading of each spec-
imen was based on the average inflammatory condition in
three consecutive microscopic fields starting from the
epithelial-connective tissue border and proceeding gradu-
ally deeper into lamina propria as described previously.13,15
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sections graded as “low” were represented by positive
stained cells >50%; sections graded “high” exhibited posi-
tive stained cells <50% on three sections/tissue at 400x
magnification according to our previous studies.16,17
Cell culture
HGFs were cultured by using an explant technique as
described previously.18 Three healthy individuals were
selected from the crown lengthening procedure for this
study. The normal gingival tissue samples were minced
using sterile techniques and washed twice in phosphate-
buffered saline (PBS) supplemented with antibiotics (100
U/ml penicillin, 100 mg/ml streptomycin and 0.25 mg/ml
of fungizone). Explants were placed into 60 mm Petri
dishes and maintained in Dulbecco’s modified Eagle’s
medium (Gibco Laboratories, Grand Island, NY, USA)
supplemented with 10% fetal calf serum (FCS; Gibco
Laboratories) and antibiotics as described above. Cell
cultures between the third and eighth passages were used
in this study.
Effect of CsA on HIF-1a expression in HGFs by
western blot
Cells arrested in G0 by serum deprivation (0.5% FCS;
48 hours) were used in the experiments.15 Nearly confluent
monolayers of HGFs were washed with serum-free
Dulbecco’s modified Eagle’s medium and immediately
thereafter exposed to various concentrations (0, 100, 200,
and 500 ng/mL) of CsA (Sigma, St Louis, MO, USA) after 24 h
incubation period. Cultures without FCS were used as
negative controls. Cells were solubilized with sodium
dodecyl sulfate-solubilization buffer (5 mM EDTA, 1 mM
MgCl2, 50 mM TriseHCl, pH 7.5 and 0.5% Trition X-100, 2 mM
phenylmethylsulfonyl fluoride, and 1 mM N-ethyl-
maleimide) for 30 minutes on ice. Then, cell lysates were
centrifuged at 12,000 g at 4C and the protein concentra-
tions determined with Bradford reagent using bovine serum
albumin as standards. Equivalent amounts of total protein
per sample of cell extracts were run on a 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and
immediately transferred to nitrocellulose membranes. The
membranes were blocked with PBS containing 3% bovine
serum albumin for 2 hours, rinsed, and then incubated with
primary antibodies anti-HIF-1a (1:500) in PBS containing
0.05% Tween 20 for 2 hours. After three washes with Tween
20 for 10 minutes, the membranes were incubated for 1
hour with biotinylated secondary antibody diluted 1:1000 in
the same buffer, washed again as described above and
treated with 1:1000 streptavidin-peroxidase solution for 30
minutes. After a series of washing steps, protein expression
was detected by chemiluminescence using an ECL detection
kit (Amersham Biosciences UK Limited, Amersham, Buck-
inghamshire, UK), and relative photographic density was
quantitated by scanning the photographic negatives on
a gel documentation and analysis system (AlphaImager
2000; Alpha Innotech Corp., San Leandro, CA, USA). Each
densitometric value was expressed as the mean  standard
deviation.Establishment of hypoxic condition for PAI-1
expression
Cells growing to about 80% confluence were transferred to
a hypoxic chamber with auto purge airlock (NexBiOxy;
Unimed Healthcare Inc., Taipei, Taiwan). Environmental
hypoxic conditions (1%) were achieved in an airtight
humidified chamber and continuously flushed with a gas
mixture containing 5% CO2 and 95% N2. Maintenance of the
desired O2 concentration was constantly monitored during
incubation using a microprocessor-based oxygen controller.
Normoxic conditions were defined as 20% O2, 5% CO2 at
37C. The culture period and western blot by using anti-PAI-
1 antibody (Santa Cruz Biotechnology) were as described
above.
Statistical analysis
Three replicates of each experiment were performed for
each test to ensure reproducibility. For testing of differ-
ences in the HIF-1a between normal healthy gingival tissues
and CsA-induced gingival overgrowth specimens, Fisher’s
exact test was applied for the statistical analysis of the
results. The significance of the results obtained from
control and CsA-treated HGFs was statistically analyzed by
Kruskal-Wallis test. Tests of differences of the treatments
were analyzed by Duncan’s test. A p-value <0.05 was
considered to be statistically significant.
Results
HIF-1a staining in gingival tissue was stronger in CsA-
induced gingival overgrowth group than normal gingival
group (p < 0.05). Fig. 1A represents gingival tissue obtained
from normal gingival group with faint HIF-1a expression. In
CsA-induced gingival overgrowth group, intensive red-
brown color staining for HIF-1a expression was observed
mainly in the cytoplasm of fibroblasts, epithelial cells, and
inflammatory cells (Fig. 1B).
HIF-1a expression in CsA-induced gingival overgrowth
specimens with low or high levels of inflammation is listed
in Table 1. Differences in HIF-1a expression between tissues
with low and high levels of inflammation were subsequently
analyzed using Fisher’s exact test. A significantly greater
HIF-1a expression was noted in CsA-induced gingival over-
growth tissues with high levels of inflammation (pZ 0.041).
To examine the effect of CsA on the HIF-1a expression,
HGFs were treated with CsA and the levels of protein were
measured. The effects of CsA on the HIF-1a expression in
three different cell strains were similar, and their intra-
cellular variations were limited. Expression of HIF-1a in
HGFs challenged with CsA was directly assessed in cell
lysates using western blot analysis (Fig. 2A). CsA was found
to upregulate HIF-1a protein expression in a dose-
dependent manner (p < 0.05). From the AlphaImager
2000, the levels of the HIF-1a protein increased about 3.5,
3.0, and 1.4 fold after exposure to 100, 200, and 500 ng/ml
CsA, respectively (Fig. 2B).
Previously, CsA was found to increase PAI-I protein
expression in HGFs.12 Hypoxia could enhance fibrogenesis
via PAI-1 protein involved in ECM modification. As shown in
Figure 1 (A) Very faint immunoreactivity of HIF-1a was observed in normal human gingival tissues (400). (B) Strong immuno-
staining for HIF-1a was noted in the CsA-induced gingival overgrowth specimens. HIF-1a was evident as intensive redbrown color in
the cytoplasm of fibroblasts, epithelial cells and inflammatory cells (200).
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expression in a dose-dependent manner under environ-
mental hypoxia and normoxic condition (p < 0.05). From
the AlphaImager 2000, the levels of the PAI-1 protein
increased about 1.3, 2.0, and 2.5 fold after exposure to
100, 200, and 500 ng/ml CsA, respectively, in normoxic
conditions (Fig. 3B). In environmental hypoxia, the levels of
the PAI-1 protein increased about 2.2, 2.7, and 3.2 fold
after exposure to 100, 200, and 500 ng/ml CsA, respectively
(Fig. 3B). In addition, CsA-induced PAI-1 protein levels were
significantly augmented in environmental hypoxia
compared to normoxic condition (p < 0.05).
To investigate the axis between HIF-1a and PAI-1 in CsA-
induced gingival overgrowth further, HIF-1a inhibitor
CAY10585 was utilized in CsA-stimulated HGFs. CsA mark-
edly increased both HIF-1a and PAI-1 protein expression,
which was abolished by the addition of CAY10585 under
hypoxic condition, respectively (Fig. 4). Taken together,
hypoxia through HIF-1a can stimulate PAI-1 accumulation
that may enhance CsA-induced gingival overgrowth.
Discussion
Hypoxia plays an important role in regulating a variety of
physiological responses as well as in pathological situations.
At sites of inflammation, tissue oxygen levels decrease and
generate hypoxic stress, which further aggravates and
accelerates inflammation and tissue damage.19 HIF-1a is an
important mediator of hypoxia signaling. To the best of our
knowledge, this is the first report of HIF-1a expression
being upregulated in CsA-induced gingival overgrowth
specimens compared with normal gingival tissues. StrongTable 1 The results of hypoxia-inducible factor-1a (HIF-
1a) expression and the grade of inflammation in cyclo-
sporine A-induced gingival overgrowth tissues.
Inflammation high Inflammation low
HIF-1a high 7 1
HIF-1a low 2 5
A significantly greater HIF-1a expression was noted in cyclo-
sporine A-induced gingival overgrowth tissues with high levels of
inflammation as compared to tissues with low levels of inflam-
matory cell infiltrates by Fisher’s exact test (p Z 0.041).immunostaining for HIF-1a was detected in fibroblasts,
epithelial cells, and inflammatory cells. In addition, the
expression of HIF-1a was also shown to increase with the
grade of inflammation in CsA-induced gingival overgrowth
specimens. The reasons are not clear, but it might be
explained as follows. Many studies have suggested that the
plaque-induced inflammation is associated with the onset
or the severity of drug-induced overgrowth,2 and histolog-
ical findings have shown the presence of some degree of
inflammatory infiltrate in the overgrown gingival
tissues.15,17 In addition, Ng et al10 have reported that theFigure 2 (A) Expression of HIF-1a protein by HGFs in the
presence of 0, 100, 200 and 500 ng/ml CsA. Cells were exposed
to CsA for a 24 h incubation period. b-actin was performed in
order to monitor equal protein loading. (B) Levels of HIF-1a
protein treated with CsA were measured by AlphaImager 2000.
The relative level of HIF-1a protein expression for each sample
was normalized against b-actin signal and the control was set
as 1.0. Optical density values represent the means of three
different HGF strains standard deviations. Triplicate experi-
ments were performed. * represents significant difference
from control values with p < 0.05.
Figure 3 (A) Effects of CsA on PAI-1 protein expression in
HGFs under normoxic and hypoxia conditions. (B) The relative
level of PAI-1 protein expression for each sample was normal-
ized against b-actin signal and the control was set as 1.0.
Optical density values represent the means of three different
HGF strains standard deviations. Triplicate experiments were
performed. * represents significant difference from control
values with p < 0.05. # represents statistically significant
between normoxic and hypoxia conditions; p < 0.05.
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and infiltrating inflammatory cells in chronic periodontitis
implies an important intracellular function of the HIF-1a
pathway in periodontal inflammation. Our results suggest
that CsA may predispose to fibrosis via HIF-1a over-
expression under an inflammatory environment.
HIF-1a is consistently and dramatically upregulated in
a variety of fibrotic diseases.4e6 In this study, we found
that the upregulation of HIF-1a expression in HGFs
stimulated by CsA. Chronic hypoxia has been newly
proposed as a common mechanism of tubulointerstitial
fibrosis in the progression of various chronic inflamma-
tory renal diseases,4,20 where PAI-1 plays an important
role in the accumulation of ECM through inhibition ofFigure 4 Effects of CsA on PAI-1 and HIF-1a expression in
HGFs with or without HIF-1a inhibitor CAY10585 as indicated by
western blot.plasmin-dependent ECM degradation. HIF-1a can induce
expression of profibrogenic genes such as PAI-1.11 Recent
results suggest that PAI-1 expression is significantly
upregulated in CsA-induced gingival overgrowth speci-
mens.12 We have found that CsA could upregulate PAI-1
protein expression under hypoxia than normoxia. In
addition, PAI-1 protein was markedly abolished by HIF-1a
inbitior CAY10585 treatment under hypoxic condition.
Hypoxic augmentation of the PAI-1 is, at least in part,
responsible for the fibrotic phenotype of CsA-induced
gingival overgrowth by driving the steady state of ECM
metabolism to a state of excessive accumulation. Our
data suggest that HIF-1a may exert its profibrotic effect
through the upregulation of CsA-induced PAI-1 protein
accumulation.
Recently, it has been known that CsA induces trans-
forming growth factor-b1 (TGF-b1) expression in gingivalFigure 5 Model proposing a role for HIF-1a/PAI-1 in the
progression of CsA-induced gingival overgrowth. Gingival tissue
inflammation could generate hypoxic stress and CsA increase
HIF-1a expression. As a consequence of hypoxia in HGFs HIF-1a
is stabilized, resulting in increased expression of PAI-1, thus
promoting the accumulation of ECM.
Hypoxia and gingival overgrowth 63fibroblasts.21 HIF-1a was also found to mediate TGF-b-in-
duced PAI-1 production in alveolar macrophages in pulmo-
nary fibrosis.22 Therefore, the CsA-induced HIF-1a and PAI-1
protein expression in this study could be the effects of CsA-
induced TGF-b1 expression. The interaction among TGF-b1,
HIF-1a, and PAI-1 is worthy of further investigation.
As far as we known, this is the first systematic attempt
to evaluate the role of HIF-1a expression in CsA-induced
gingival overgrowth in human at both in vivo and in vitro.
We have demonstrated that HIF-1a is elevated in CsA-
induced gingival overgrowth than normal gingival tissues.
Data from our in vitro experiments show that CsA is capable
of stimulating HIF-1a expression in HGFs. Hypoxia through
HIF-1a may promote fibrogenesis via stimulation of PAI-1
that promotes ECM accumulation in gingival connective
tissues (Fig. 5).
Further research is required, however, including
knockout experiments on HIF-1a, using small interfering-
RNA for example, specifically to determine whether CsA-
induced gingival overgrowth evolves solely as a result of
increased/altered de novo synthesis and deposition of HIF-
1a by CsA. In addition, it would be interesting to know how
other HIF-1a regulated profibrogenic factors such as
connective tissue growth factor or tissue inhibitor of matrix
metalloproteinase-1 will perform in hypoxic conditions.
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